Jay Flatley and John Martin to be Named Recipients of Life Sciences Leadership Award at CLSA’s 2017 Pantheon DiNA Awards
Esteemed Industry Leaders to be Honored for Contributions to California’s Thriving Life Sciences Sector on Nov. 10
SAN DIEGO & SAN FRANCISCO – OCTOBER 17, 2017 – California Life Sciences Association (CLSA), the statewide public policy and business leadership trade association representing California’s life sciences industry, has announced the winners of its 2017 Life Sciences Leadership Award, which honors California’s most innovative and dedicated life sciences leaders for their ongoing commitments and contributions to California’s life sciences communities.
The award will be presented to Jay Flatley, executive chairman and former CEO at Illumina, and John Martin, Ph.D., executive chairman at Gilead Sciences, as part of CLSA’s 2017 Pantheon DiNATM Awards ceremony on November 10 at the Marriott Marquis in San Francisco.
“Through the Life Sciences Leadership Award, we have the opportunity to recognize those individuals who have dedicated their careers to driving innovation and collaboration in California’s life sciences. Without the leadership and relentless dedication of John Martin and Jay Flatley, California’s life sciences industry would not be the model for the world that it is today,” said Sara Radcliffe, President and CEO, California Life Sciences Association (CLSA). “Please join us at CLSA’s 2017 Pantheon DiNATM Awards ceremony to honor our 2017 Life Sciences Leadership Award recipients, and all our Pantheon Award winners.”
Jay Flatley, Executive Chairman and Former CEO at Illumina
As CEO from 1999 until 2016, Mr. Flatley took Illumina from $1.3M in sales in 2000 to $2.2B in 2015, representing a compound annual growth rate of 64 percent. He oversaw the company’s expansion from microarrays into next-generation sequencing (NGS) with the acquisition of Solexa in 2006, and from research into clinical and applied markets. Today, Mr. Flatley chairs the Board of Directors for Illumina and its subsidiary, Helix. He also serves on the Boards of Directors at Coherent, Denali, Juno, Dodo Omnidata and on the Board of Trustees for The Salk Institute and is an Advisory Board member for UC San Diego’s Moores Cancer Center. View full biography.
John Martin, Ph.D., Executive Chairman at Gilead Sciences
Dr. Martin joined Gilead Sciences in 1990 and was appointed Executive Chairman in 2016. He previously served as Chairman and CEO from 2008 to 2016 and President and CEO from 1996 to 2008. Prior to joining Gilead, Dr. Martin held several leadership positions at Bristol-Myers Squibb and Syntex Corporation. He previously served as President of the International Society for Antiviral Research, and Chairman of the Board of Directors of CLSA’s legacy organizations BayBio and California Healthcare Institute (CHI). He has also served on the boards of the National Institute of Allergy & Infectious Diseases Council, the Biotechnology Industry Organization, the Board of Trustees of the University of Chicago and Golden Gate University as well as on the External Scientific Advisory Board of the University of California School of Global Health. Additionally, Dr. Martin served on the Centers for Disease Control/Health Resources and Services Administration’s Advisory Committee on HIV and STD Prevention and Treatment and was a member of the Presidential Advisory Council on HIV/AIDS. View full biography.
To attend the 2017 Pantheon Awards, registration and ticket information is available at www.clsapantheon.org. The event will commence on November 10 with an opening reception at 5:30 p.m. PT, followed by the awards ceremony and dinner. Members of the press may obtain complimentary registration by contacting Will Zasadny, Director of Communications for CLSA (email@example.com). To learn more about CLSA and its offerings, please visit: www.califesciences.org.
The annual program, now in its 14th year, brings together more than 600 industry pioneers – including innovators, investors and educators – and recognizes the achievements and excellence of those dedicated to enhancing California’s life sciences community, a sector which employs nearly 300,000 Californians at over 3,000 life sciences companies.
About California Life Sciences Association (CLSA)
California Life Sciences Association (CLSA) is the state’s largest and most influential life sciences advocacy and business leadership organization. With offices in Sacramento, San Diego, South San Francisco, Los Angeles and Washington DC, CLSA works closely with industry, government, academia and others to shape public policy, improve access to innovative technologies and grow California’s life sciences economy. CLSA serves biotechnology, pharmaceutical, medical device and diagnostics companies, research universities and institutes, investors and service providers throughout the Golden State. CLSA was founded in 2015 when the Bay Area Bioscience Association (BayBio) and the California Healthcare Institute (CHI) merged. Visit CLSA at www.califesciences.org, and follow us on Twitter @CALifeSciences, Facebook, Instagram, LinkedIn and YouTube.
California Life Sciences Association (CLSA)
Will Zasadny | Director, Communications
firstname.lastname@example.org | 619-961-8848